Literature DB >> 6329599

Macrophage activation: enhanced oxidative and antiprotozoal activity.

H W Murray.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6329599     DOI: 10.1007/978-1-4757-1445-6_5

Source DB:  PubMed          Journal:  Contemp Top Immunobiol        ISSN: 0093-4054


× No keyword cloud information.
  7 in total

1.  Macrophage activation for intracellular killing as induced by a Ca2+ ionophore. Dependence on L-arginine-derived nitrogen oxidation products.

Authors:  Y Buchmüller-Rouiller; S B Corradin; J Mauël
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

2.  Oxygen-dependent leishmanicidal activity of stimulated macrophages.

Authors:  R Chakraborty; S Mukherjee; M K Basu
Journal:  Mol Cell Biochem       Date:  1996-01-12       Impact factor: 3.396

3.  Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains.

Authors:  T I Roach; A F Kiderlen; J M Blackwell
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp.

Authors:  Y Buchmüller-Rouiller; J Mauël
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

5.  Immunolocalization of superoxide dismutase in Dirofilaria immitis adult worms.

Authors:  H L Callahan; D Hazen-Martin; R K Crouch; E R James
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  Immunity to Schistosoma mansoni in guinea-pigs vaccinated with radiation-attenuated cercariae. T-cell activation of macrophages for larval killing.

Authors:  J R Gordon; D J McLaren
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

7.  Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.

Authors:  W Y Weiser; A Van Niel; S C Clark; J R David; H G Remold
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.